Most of today's gene therapies rely on viruses — and that's a problem
The next big strides in gene therapy for rare diseases may come from CRISPR and new approaches to delivery.
Stay updated with breaking news from Conner Curran. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The next big strides in gene therapy for rare diseases may come from CRISPR and new approaches to delivery.
Conner Curran, 12, has Duchenne muscular dystrophy and will participate in a trial to potentially receive the gene therapy that has improved his quality of life
The treatment of Duchenne's is in the midst of a revolution, bringing hope to a disease that inevitably left boys in a wheelchair in their teens.
Conner Curran, an 11-year-old living with Duchenne muscular dystrophy, got a different...
Conner Curran, an 11-year-old living with Duchenne muscular dystrophy, got a different...